DFB Healthcare Acquisitions Corp’s Quiet Period Set To End Tomorrow (NASDAQ:DFBHU)

DFB Healthcare Acquisitions’ (NASDAQ:DFBHU) quiet period is set to end on Wednesday, March 28th. DFB Healthcare Acquisitions had issued 25,000,000 shares in its IPO on February 16th. The total size of the offering was $250,000,000 based on an initial share price of $10.00. During the company’s quiet period, insiders and any underwriters involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

DFBHU stock opened at $10.05 on Tuesday. DFB Healthcare Acquisitions has a one year low of $10.00 and a one year high of $10.20.

WARNING: This story was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/3303406/dfb-healthcare-acquisitions-corps-quiet-period-set-to-end-tomorrow-nasdaqdfbhu.html.

About DFB Healthcare Acquisitions

DFB Healthcare Acquisitions Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Receive News & Ratings for DFB Healthcare Acquisitions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DFB Healthcare Acquisitions and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Stock Analysts’ Downgrades for April, 27th
Stock Analysts’ Downgrades for April, 27th
Ryder  PT Lowered to $76.00
Ryder PT Lowered to $76.00
The Hackett Group  Stock Rating Lowered by Zacks Investment Research
The Hackett Group Stock Rating Lowered by Zacks Investment Research
IMI  Stock Rating Lowered by Zacks Investment Research
IMI Stock Rating Lowered by Zacks Investment Research
Zacks Investment Research Upgrades Healthcare Trust Of America  to Hold
Zacks Investment Research Upgrades Healthcare Trust Of America to Hold
Croda International  Rating Reiterated by Liberum Capital
Croda International Rating Reiterated by Liberum Capital


© 2006-2018 Ticker Report. Google+.